Is vraylar a controlled substance?

Is Vraylar (cariprazine) considered a controlled substance?

No. Vraylar (cariprazine) is not classified as a controlled substance in the way drugs like opioids, benzodiazepines, or stimulants are. It is an antipsychotic medication used for certain psychiatric conditions, and it does not have a DEA schedule status like controlled drugs do.

Why isn’t Vraylar classified like some other psych meds?

Controlled-substance status usually depends on whether a drug has potential for misuse, addiction, or dependence serious enough to require tighter legal controls. Vraylar is prescribed for specific psychiatric indications and is not typically associated with the kind of abuse or dependence profile that leads to a DEA schedule classification.

Where people get confused: “requires a prescription” vs “controlled substance”

Many prescription medications are not controlled substances. Being available only by prescription does not automatically mean it is controlled. Vraylar requires a prescription, but that is different from being DEA-scheduled.

If you’re asking because of travel or workplace rules

If your goal is practical compliance (traveling with medication, custody rules, or workplace monitoring), the key point is that Vraylar is generally treated as a regular prescription medication, not a DEA-scheduled controlled drug. Carrying the prescription label (or a doctor’s note) is still wise.

Source

• DrugPatentWatch.com: Vraylar (cariprazine) patent and regulatory tracking page